ViewRay Inc (VRAY):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:ViewRay Inc (VRAY) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6487
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ViewRay Inc (ViewRay) is a medical device company that develops radiation therapy technology for the treatment of cancer. The company provides MRIdian, a radiation therapy solution that enables treatment and real-time imaging of a patient’s anatomy simultaneously. It offers MRIdian integrates MRI technology, radiation delivery, and proprietary software to locate, target, and track the position and shape of soft-tissue tumors although radiation is delivered. ViewRay’s technology MRIdian Linac uses the same split-magnet MRI system used in the MRIdian, which is designed to fit in standard radiotherapy vaults replacing X-ray guided linear accelerators. The company caters services to university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay is headquartered in Oakwood, Ohio, the US.

ViewRay Inc (VRAY) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
ViewRay Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
ViewRay Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
ViewRay Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
ViewRay Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
ViewRay Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
ViewRay Inc, Medical Equipment, Deal Details 12
Venture Financing 12
ViewRay Secures USD50 Million in Debt Financing 12
ViewRay Raises US$30 Million In Venture Financing 13
ViewRay Raises US$15 Million In Venture Financing 15
ViewRay Raises US$11 Million In Series D-1 Financing 16
ViewRay, Medical Device Company Raises US$45 Million In Series C Financing 17
Equity Offering 18
ViewRay Raises USD172.5 Million in Public Offering of Shares 18
ViewRay to Raise USD59 Million in Private Placement of Shares and Warrants 20
ViewRay Plans to Raise up to USD56.7 Million in Public Offering of Shares 22
ViewRay Raises USD49.8 Million in Private Placement of Shares 23
ViewRay Plans to Raise up to USD25 Million in Public Offering of Shares 24
ViewRay to Raise Funds through Public Offering of Shares 25
ViewRay Raises USD26 Million in Private Placement of Shares and Warrants 26
ViewRay to Raise USD13.8 Million in Private Placement of Units 27
ViewRay Raises USD0.6 Million in Third and Final Tranche of Private Placement of Shares 29
ViewRay Raises USD2 Million in Second Tranche of Private Placement of Shares 31
ViewRay Raises USD27 Million in Private Placement of Shares 33
ViewRay Postpones IPO 35
Asset Transactions 36
Henry Ford Health System Acquires Linear Accelerator Technology from ViewRay 36
ViewRay Inc – Key Competitors 37
ViewRay Inc – Key Employees 38
ViewRay Inc – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Recent Developments 40
Financial Announcements 40
Aug 03, 2018: Viewray reports second quarter 2018 financial results 40
May 10, 2018: ViewRay Reports First Quarter 2018 Financial Results 41
Mar 12, 2018: ViewRay Reports Fourth Quarter and Full Year 2017 Financial Results 42
Jan 08, 2018: ViewRay Announces Preliminary Fourth Quarter and Fiscal Year 2017 Results 43
Nov 13, 2017: ViewRay Reports Third Quarter 2017 Financial Results 44
Aug 07, 2017: ViewRay Reports Second Quarter 2017 Financial Results 45
May 15, 2017: ViewRay Reports First Quarter 2017 Financial Results 46
Mar 16, 2017: ViewRay Reports Fourth Quarter and Full Year 2016 Financial Results 47
Corporate Communications 49
Feb 07, 2018: ViewRay Appoints Scott Huennekens and Daniel Moore to its Board of Directors 49
Product News 50
Sep 21, 2017: ViewRay MRIdian to be Featured in 21 Presentations from Seven Leading Centers at ASTRO 50
Sep 20, 2017: ViewRay to Host Analyst & Investor Meeting at ASTRO in San Diego 51
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52

List of Tables
ViewRay Inc, Medical Equipment, Key Facts, 2017 2
ViewRay Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
ViewRay Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
ViewRay Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
ViewRay Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
ViewRay Inc, Deals By Market, 2012 to YTD 2018 9
ViewRay Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
ViewRay Secures USD50 Million in Debt Financing 12
ViewRay Raises US$30 Million In Venture Financing 13
ViewRay Raises US$15 Million In Venture Financing 15
ViewRay Raises US$11 Million In Series D-1 Financing 16
ViewRay, Medical Device Company Raises US$45 Million In Series C Financing 17
ViewRay Raises USD172.5 Million in Public Offering of Shares 18
ViewRay to Raise USD59 Million in Private Placement of Shares and Warrants 20
ViewRay Plans to Raise up to USD56.7 Million in Public Offering of Shares 22
ViewRay Raises USD49.8 Million in Private Placement of Shares 23
ViewRay Plans to Raise up to USD25 Million in Public Offering of Shares 24
ViewRay to Raise Funds through Public Offering of Shares 25
ViewRay Raises USD26 Million in Private Placement of Shares and Warrants 26
ViewRay to Raise USD13.8 Million in Private Placement of Units 27
ViewRay Raises USD0.6 Million in Third and Final Tranche of Private Placement of Shares 29
ViewRay Raises USD2 Million in Second Tranche of Private Placement of Shares 31
ViewRay Raises USD27 Million in Private Placement of Shares 33
ViewRay Postpones IPO 35
Henry Ford Health System Acquires Linear Accelerator Technology from ViewRay 36
ViewRay Inc, Key Competitors 37
ViewRay Inc, Key Employees 38
ViewRay Inc, Other Locations 39
ViewRay Inc, Subsidiaries 39

List of Figures
ViewRay Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
ViewRay Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
ViewRay Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
ViewRay Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
ViewRay Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
ViewRay Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
ViewRay Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
ViewRay Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[ViewRay Inc (VRAY):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • LG Corp (003550):企業の財務・戦略的SWOT分析
    LG Corp (003550) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Maruzen Petrochemical Co Ltd:企業の戦略的SWOT分析
    Maruzen Petrochemical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Senomyx Inc (SNMX):企業の財務・戦略的SWOT分析
    Summary Senomyx Inc (Senomyx) focuses on the discovery, development and commercialization of novel flavor ingredients and natural high intensity sweeteners (HIS) to packaged food, beverage and ingredient supply industries. The company discovers and develops novel flavor ingredients and natural HIS t …
  • Cullinan Holdings Limited
    Cullinan Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Cullinan Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Zain Group:企業の戦略・SWOT・財務情報
    Zain Group - Strategy, SWOT and Corporate Finance Report Summary Zain Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Blue Apron Inc. (APRN):企業の財務・戦略的SWOT分析
    Blue Apron Inc. (APRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Five Prime Therapeutics Inc (FPRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Five Prime Therapeutics Inc (Five Prime) is a clinical state biopharmaceutical company focusing on the research and development of novel treatments for cancer and inflammatory disorders. The company’s developmental pipeline is based on the discovery platform and library of therapeutic protei …
  • GeeCee Ventures Ltd (GEECEE):企業の財務・戦略的SWOT分析
    GeeCee Ventures Ltd (GEECEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Pon Holdings BV:企業の戦略・SWOT・財務情報
    Pon Holdings BV - Strategy, SWOT and Corporate Finance Report Summary Pon Holdings BV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Harpoon Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Harpoon Therapeutics Inc (Harpoon Therapeutics) is a biotechnology company that offers solutions for immune-oncology diseases. The company provides products portfolio such as of HPN424, prostate specific antigen and harnesses a technology named TriTAC technology. It employs TriTAC technology …
  • Pyng Medical Corp:医療機器:M&Aディール及び事業提携情報
    Summary Pyng Medical Corp (Pyng Medical), a subsidiary of Teleflex Medical Canada Inc, is a medical device company that manufactures and markets trauma and resuscitation products. The company offers products such as fast1 intraosseous infusion system, fastresponder sternal intraosseous device, mat t …
  • Cara Therapeutics Inc (CARA):製薬・医療:M&Aディール及び事業提携情報
    Summary Cara Therapeutics Inc (Cara Therapeutics) is a biotechnology company that develops and commercializes chemical entities for acutepain, chronic pain and pruritus. The company offers kappa opioid receptor agonists in the therapeutic areas of acute pain, chronic pain, neuropathic pain and pruri …
  • Yissum Research Development Company of the Hebrew University of Jerusalem Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Yissum Research Development Company of the Hebrew University of Jerusalem Ltd (YRDC), a subsidiary of Hebrew University of Jerusalem, is a technology transfer company. The company offers marketing and licensing the inventions, products, and technologies developed by the university's faculty, …
  • Superdry Plc:企業の戦略・SWOT・財務分析
    Superdry Plc - Strategy, SWOT and Corporate Finance Report Summary Superdry Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • WEX Pharmaceuticals Inc:企業の戦略的SWOT分析
    WEX Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Mereo Biopharma Group Plc (MPH):企業の財務・戦略的SWOT分析
    Summary Mereo Biopharma Group Plc (Mereo), formerly Mereo Biopharma Group Ltd is a specialty bio-pharmaceutical company which develops novel medicines for the treatment of rare and specialty diseases. The company’s pipeline products include BPS-804, which is used for the treatment of brittle bone sy …
  • Gujarat Sidhee Cement Ltd.:企業の戦略・SWOT・財務情報
    Gujarat Sidhee Cement Ltd. - Strategy, SWOT and Corporate Finance Report Summary Gujarat Sidhee Cement Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Fibrocell Science Inc (FCSC):企業の財務・戦略的SWOT分析
    Fibrocell Science Inc (FCSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Ultrapar Participacoes S.A.:企業の戦略・SWOT・財務情報
    Ultrapar Participacoes S.A. - Strategy, SWOT and Corporate Finance Report Summary Ultrapar Participacoes S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Pension Insurance Corporation plc:企業の戦略・SWOT・財務情報
    Pension Insurance Corporation plc - Strategy, SWOT and Corporate Finance Report Summary Pension Insurance Corporation plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆